Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease

REFERENCES

• Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25(2):234–9.
   Google Scholar
• Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol. 2001;28(10):2230–7.
   PubMed Web of Science ®Google Scholar
• Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 1985;28(3):249–55.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Lopez-Acuna D, Gittelsohn AM. Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. Arthritis Rheum. 1983;26(12):1465–71.
   PubMed Web of Science ®Google Scholar
• Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001;134(12): 1087–95.
   Google Scholar
• Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermato-myositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.
   PubMed Web of Science ®Google Scholar
• Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implica-tions: a Scottish population-based cohort study. Br J Cancer. 2001;85(1):41–5.
   Google Scholar
• Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szod-oray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol. 2008;35(3):438–44.
   Google Scholar
• Rider LG, Shamim E, Okada S, Pandey JP, Targoff IN, O'Hanlon TP, et al. Genetic risk and protective factors for idiopathicinflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum. 1999;42(6):1285–90.
   Google Scholar
• Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol. 2001;144(4):825–31.
   Google Scholar
• Hu WJ, Chen DL, Min HQ. Study of 45 cases of nasopharyngeal carcinoma with dermatomyositis. Am J Clin Oncol. 1996;19(1): 35–8.
   Google Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403–7.
   PubMed Web of Science ®Google Scholar
• Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermato-myopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46(4):626–36.
   PubMed Web of Science ®Google Scholar
• Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med. 1970;48(6):715–23.
   PubMed Web of Science ®Google Scholar
• Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med. 1986;80(2): 329–32.
   Google Scholar
• Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ 3rd. Poly-myositis-dermatomyositis and malignant lesions: does an asso-ciation exist? Mayo Clin Proc. 1986;61(8):645–53.
   Google Scholar
• Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermato-myositis or polymyositis. Clin Exp Rheumatol. 1996;14(3): 263–74.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther. 2010;12(2):R70.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi YH, Oh MD, Nam TS, Chung MH, Pai HJ, Choe KW. A clinical Analysis of 100 Patients with dermatomyositis-polymyositis. Korean J Med. 1990;39: 812–23.
   Google Scholar
• Lee SW, Jung SY, Park MC, Park YB, Lee SK. Malignancies in Korean patients with inflammatory myopathy. Yonsei Med J. 2006;47(4):519–23.
   Google Scholar
• Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64–71.
   PubMed Web of Science ®Google Scholar
• Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malig-nancies in 136 Japanese patients with dermatomyositis, poly-myositis and clinically amyopathic dermatomyositis. Mod Rheumatol 2011;21:175–85.
   Web of Science ®Google Scholar
• Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retro-spective study. Int J Dermatol. 2002;41(11):729–34.
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Welfare. Nationwide cancer incidence in Korea 2008. Ministry of Health and Welfare, Seoul. 2010.
   Google Scholar
• Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, et al. Interstitial lung disease in patients with polymyositis, dermato-myositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44(10):1282–6.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wu CY, Shen JL. Predicting factors of interstitial lung disease in dermatomyositis and polymyositis. Acta Derm Vene-reol. 2007;87(1):33–8.
   Google Scholar
• Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38:1636–43.
   PubMed Web of Science ®Google Scholar